Bacterial meningitis in children: diagnosis and therapy. A review of recent developments.
Stutman
H R
HR
Marks
M I
MI
D000367:Age Factors; D000617:Aminoglycosides / Q000627:therapeutic use; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000302:isolation & purification; D002439:Cefotaxime / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D002444:Cefuroxime / Q000627:therapeutic use; D002555:Cerebrospinal Fluid / Q000166:cytology / Q000382:microbiology; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008581:Meningitis / Q000175:diagnosis / Q000188:drug therapy; D008583:Meningitis, Haemophilus / Q000188:drug therapy; D008584:Meningitis, Listeria / Q000188:drug therapy; D008585:Meningitis, Meningococcal / Q000188:drug therapy; D008586:Meningitis, Pneumococcal / Q000188:drug therapy; D011379:Prognosis; D013129:Spinal Puncture
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002701:Chloramphenicol; D002443:Ceftriaxone; D000667:Ampicillin; D002439:Cefotaxime; D002444:Cefuroxime